
Sign up to save your podcasts
Or
Send us a text
Dr. Morgan Levine, PhD (https://www.morganlevinelab.com/) is Assistant Professor of Pathology and Epidemiology, at the Yale School of Medicine. Dr. Levine is also a member of both the Yale Combined Program in Computational Biology and Bioinformatics, and the Yale Center for Research on Aging. Her work relies on an interdisciplinary approach, integrating theories and methods from statistical genetics, computational biology, and mathematical demography to develop biomarkers of aging for humans and animal models using high-dimensional -omics data. As PI or co-Investigator on multiple NIH-, Foundation-, and University-funded projects, she has extensive experience using systems-level and machine learning approaches to track epigenetic, transcriptomic, and proteomic changes with aging and incorporate this information to develop measures of risk stratification for major chronic diseases, such as cancer and Alzheimer’s disease. Dr. Levine's work also involves development of systems-level outcome measures of aging, aimed at facilitating evaluation for gero-protective interventions. A number of the existing biological aging measures she has developed are being applied in both basic and observational research.
Support the show
5
22 ratings
Send us a text
Dr. Morgan Levine, PhD (https://www.morganlevinelab.com/) is Assistant Professor of Pathology and Epidemiology, at the Yale School of Medicine. Dr. Levine is also a member of both the Yale Combined Program in Computational Biology and Bioinformatics, and the Yale Center for Research on Aging. Her work relies on an interdisciplinary approach, integrating theories and methods from statistical genetics, computational biology, and mathematical demography to develop biomarkers of aging for humans and animal models using high-dimensional -omics data. As PI or co-Investigator on multiple NIH-, Foundation-, and University-funded projects, she has extensive experience using systems-level and machine learning approaches to track epigenetic, transcriptomic, and proteomic changes with aging and incorporate this information to develop measures of risk stratification for major chronic diseases, such as cancer and Alzheimer’s disease. Dr. Levine's work also involves development of systems-level outcome measures of aging, aimed at facilitating evaluation for gero-protective interventions. A number of the existing biological aging measures she has developed are being applied in both basic and observational research.
Support the show
14,198 Listeners
39,948 Listeners
2,170 Listeners